Vaginal Intraepithelial Neoplasia III Detected After Hysterectomy for Benign Conditions Daron G

Total Page:16

File Type:pdf, Size:1020Kb

Vaginal Intraepithelial Neoplasia III Detected After Hysterectomy for Benign Conditions Daron G Brief Reports Vaginal Intraepithelial Neoplasia III Detected After Hysterectomy for Benign Conditions Daron G. Ferris, MD; Mark J. Messing, MD; and John H. Crosby, MD Augusta, G eorgia Because primary vaginal cancer is rare, many experts dis­ true vaginal cancer precursor, the innocent disregard of courage routine cytologic sampling of the vaginal vault recommended screening practices averted significant following hysterectomy for benign circumstances. The morbidity and possibility mortality for this otherwise following report describes a case of vaginal intraepithe­ healthy woman. lial neoplasia III (VAIN III) detected by a vaginal vault Key words. Vaginal diseases; vaginal neoplasia; vaginal Papanicolaou smear obtained from an asymptomatic 57- smears. vear-old woman 23 years after she had a total abdominal hysterectomy for a benign condition. As VAIN III is a (J Fam Pract 1995; 40:81 -85) Primary carcinoma of the vagina is uncommon, estimated trol (DES) and for women who have had a hysterectomy to comprise less than 0.5% o f all malignancies,1 and 1% to for cervical neoplasia.4-7 Vaginal smears are also occasion­ 2% of female genital tract malignancies.2 Most (85%) af­ ally obtained for hormonal status evaluation. Few women flicted women are older than 50 years of age.3 Except for are screened regularly by vaginal cytologic sampling if more advanced cases in which vaginal bleeding and vagi­ they have had a hysterectomy for benign conditions. nal discharge may be noted, many patients remain asymp­ Some authors advocate boldly against Pap smear testing tomatic.2"3 Primary carcinoma of the vagina is often de­ in this circumstance because they believe it is unnecessary tected unexpectantly during evaluation for other lower unless the surgery was for cervical dysplasia or cancer.8-9 The following report illustrates a case o f vaginal intraepi­ genital tract conditions. Because of the rarity of the dis­ thelial neoplasia III (VAIN III) detected by a vaginal vault ease, the older population affected, and the silent nature Pap smear in a woman who had had a hysterectomy many of early disease stages, meaningful surveillance proves years earlier for a benign condition. challenging for patients, clinicians, and the health care system. The Papanicolaou (Pap) smear, originally collected direcdy from the vagina, is the most effective test for Case Report detection of carcinoma of the vagina. In contemporary A 57-year-old woman, gravida 7 para 5 abortus 2, pre­ practice, true vaginal smears are not often performed. sented for an initial visit history and physical examination. Generally, routine vaginal smears are performed only for She denied vaginal bleeding and pelvic pain. She was not women who have been exposed in utero to diethylstilbes- currently sexually active because of her husband’s impo­ tence induced by diabetes mellitus. H er medical history was notable for multiple surgical procedures: total abdominal hysterectomy in 1970 for Subtnitted, revised, August 24, 1994. chronic cervicitis with cystourethrocele and chronic pelvic trom the Medical Effectiveness Education and Research Program, Departments of congestion; bilateral salpingo-oophorectomy, appendec­ family Medicine (D.G.F.) and Obstetrics an d Gynecology (M.J.M.), M edical College of Georgia, and the Pathology and Laboratory Medicine Sendee, Veterans Adminis­ tomy and Burch procedure in 1983 for vaginal relaxation tration Medical Center (J.H.C.), Augusta, Georgia. Requests for reprints should be and menopause; and two postabortion dilation and curet­ addressed to Daron G. Ferris, MD, Department o f Family Medicine, Medical College of Georgia, Augusta, GA 30912-3500. tage procedures. She had no chronic medical problems. © 1995 Appleton & Lange ISSN 0094-3509 The Journal of Family Practice, Vol. 40, No. l(Jan.), 1995 81 Vaginal Neoplasia Ferris, Messing, and Crosby Figure 1. The Pap smear was interpreted as severe squamous dysplasia with human papillomavirus changes indicative of VAIN III. The vaginal smear contained squamous cells with enlarged, hyperchromatic nuclei. Compare the abnormal cell Figure 2. The vaginal lesion following 5% acetic acid application (arrow) with the adjacent normal intermediate squamous cell There are dense acetowhite epithelium, smooth margins, anda (Pap stain; X400). moderately coarse punctation vascular pattern (arrow). Her family history was o f interest because her grand­ brown epithelium in the right vaginal vault (Figure 3) mother had had cervical cancer and another distant rela­ Three histologic specimens of the iodine-negative vagina! tive had developed vulvar cancer. A physical examination lesions were obtained by biopsy. Hemostasis was estab revealed a healthy middle-aged woman. A Pap smear was lished by applying silver nitrate and a paste o f Monsel’s obtained from the normal appearing vaginal vault. Oth­ (ferric subsulfate) solution. The colposcopic evaluation erwise her physical examination was unremarkable. was VAIN III, possible microinvasive carcinoma. Her Pap smear was interpreted as severe squamous The histologic specimens (Figure 4) were inter dysplasia with human papillomavirus (HPV) changes indic­ preted as VAIN III with condylomatous changes that ative of VAIN III (Figure 1). She was then scheduled for col- correlated with the cytology report and colposcopic eval! poscopic examination for apparent vaginal disease. uation. The patient was referred to a gynecologic oncol With further questioning, the patient denied a his­ ogist for treatment. Because of concern about the possi tory of venereal warts. She claimed smoking one pack of bility o f an occult invasive lesion, the patient underwent , cigarettes per day. H er age o f first sexual intercourse was partial vaginectomy. The resulting vagina was shortencc 19, and she reported only one lifelong sexual partner. She to approximately 5 cm. Her postoperative recovery w denied a history of abnormal Pap smears, cancer, and unremarkable. The resected vaginal mucosa showed a radiation therapy. tensive residual VAIN ranging from VAIN I to VAIN III A careful colposcopic examination was performed of with no stromal invasion. Vaginal intraepithelial neoplasi the vagina, vulva, and perineum. A small area o f keratosis was present at some resection margins. was noted in the right posterior vaginal vault during the saline examination. Following 5% acetic acid application, a 2-cm X 3-cm area of acetowhite epithelium was ob­ served in the adjoining region (Figure 2). A moderately Discussion coarse punctation vascular pattern with wide intercapil­ lary distances was noted. Petechial hemorrhages associ­ Vaginal intraepithelial neoplasia is typically detected byai ated with trauma were also seen in the proximal vagina. abnormal cytology report.10-11 The disease is most com One-half strength Lugol’s iodine solution was then ap­ monly noted in the sixth decade o f life.10-12 Patients an plied to the vagina with cotton swabs. Multifocal iodine­ usually asymptomatic,10-11 but vaginal bleeding, dyspa negative lesions were observed within a larger area o f light reunia, postcoital spotting, and leukorrhea are occasion 82 The lournal of Family Practice, Vol. 40, No. l(Ian.), 199 Vaginal Neoplasia Ferris, Messing, and Crosby 41% had had a hysterectomy initially for benign condi­ tions.6’7’14 It must be recognized, however, that nearly the same percentage of women in the general population o f equal age will also have had a hysterectomy. Typically, VAIN is multifocal,14 and is usually located in the proxi­ mal one third of the vagina.10’11’14 Virally induced VAIN is also commonly associated with a multicentric disease process of the lower genital tract.14 Colposcopy of the vagina and directed biopsy are required to confirm a diagnosis of VAIN. The indications for vaginal colposcopy are listed in the Table.15 The col- poscopic appearance of VAIN varies according to the stage o f disease.15 In this case, a high-grade vaginal lesion was expected, based on the dense acetowhite epithelium, coarsely dilated punctation with a wide intercapillary dis­ tance, a smooth margin, and multifocal, distinct iodine­ negative (a positive Schiller’s test result) epithelium.10 Mosaic vascular patterns are rarely observed in VAIN.10 An adjoining area o f keratosis was also observed by col- poscopic examination. The absence of atypical vessels, papil­ lary or exophytic projections, ulceration or erosion, and a nodular configuration limited the colposcopic evaluation Figure 3. The vaginal lesion following application of Lugol’s to a severe, premalignant process.15 The cytologic, colpo­ iodine solution. Iodine-negative or yellow epithelium (arrow) represent the dysplastic epithelium. Normal epithelium appears scopic, and histologic correlation confirmed VAIN III. a mahogony brown color. The differential diagnosis included residual neoplasia previously undetected at the time of hysterectomy, recur­ rent disease considering the same circumstances, meta­ ally reported.11’13 The lesions are generally not apparent static disease, atrophy of the vagina, trauma, infection, or by naked-eye examination o f the vagina.11 vaginal adenosis.16 The pathology report o f the previously Although vaginal cancer6’7 and VAIN12 are seldom excised uterus indicated chronic cervicitis. The possibility noted in women following hysterectomy for malignant or o f earlier vaginal disease cannot be excluded because there benign conditions,7-10 reports of women who developed was no mention of examination by colposcopy prior to vaginal cancer following
Recommended publications
  • Hysteroscopy with Dilation and Curretage (D & C)
    501 19th Street, Trustees Tower FORT SANDERS WOMEN’S SPECIALISTS 1924 Pinnacle Point Way Suite 401, Knoxville Tn 37916 P# 865-331-1122 F# 865-331-1976 Suite 200, Knoxville Tn 37922 Dr. Curtis Elam, M.D., FACOG, AIMIS, Dr. David Owen, M.D., FACOG, Dr. Brooke Foulk, M.D., FACOG Dr. Dean Turner M.D., FACOG, ASCCP, Dr. F. Robert McKeown III, M.D., FACOG, AIMIS, Dr. Steven Pierce M.D., Dr. G. Walton Smith, M.D., FACOG, Dr. Susan Robertson, M.D., FACOG HYSTEROSCOPY WITH DILATION AND CURRETAGE (D & C) Please read and sign the following consent form when you feel that you completely understand the surgical procedure that is to be performed and after you have asked all of your questions. If you have any further questions or concerns, please contact our office prior to your procedure so that we may clarify any pertinent issues. Definition: HysterosCopy is an outpatient procedure that allows your doctor direct visualization of the inside of the uterine cavity (womb) by inserting a thin lighted telescope (hysteroscope) through the vagina (birth canal) and cervix, without making an abdominal incision. This procedure enables your doctor to examine the lining of the uterus, look for polyps, fibroids, scar tissue, blockages of the fallopian tubes, and abnormal partitions. In addition, this procedure allows your doctor to remove or surgically treat many of the abnormalities seen. Dilation and Curettage (D&C) allows your doctor to take a sample of the tissue that lines your uterus (endometrium) and/or to remove polyps, fibroid tumors, or hyperplasia. Suction D&C is used in cases of miscarriage.
    [Show full text]
  • Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A
    Gyn Oncology Colposcopy I. Basic Science/Mechanisms of Disease A. Genetics 1. Describe the clinical relevance of viral oncogenes. 2. Describe the role of aneuploidy in the pathogenesis of neoplasia. 3. Describe the inheritance patterns for malignancies of the pelvic organs and breast. 4. Describe the cell replication cycle, and identify the phases of the cycle most sensitive to radiation and chemotherapy. 5. Describe the genetic basis for tumor immunotherapy. B. Physiology 1. Describe the ability of vital organ systems to tolerate cancer therapy. 2. Describe the changes in cellular physiology that result from injury due to radiation and chemotherapy. 3. Describe the metabolic changes that occur in patients with a malignancy of the pelvic organs or breast. C. Embroyology 1. Describe the embryology of gonadal migration and its role in the pathogenesis of epithelial cell tumors. 2. Describe the pathogenesis of gonadal tumors in patients with gonadal dysgenesis. 3. Describe the embryologic precursors of ovarian germ cell tumors. D. Anatomy 1. Describe the gross histologic anatomy of the pelvic organs and breast. 2. Describe the vascular, lymphatic, and nerve supply to each of the pelvic organs. 3. Describe the anatomic relationship between the reproductive organs and other viscera, such as bladder, ureters, and bowel. 4. Describe the likely changes in the anatomic relationships of the pelvic and abdominal viscera created by surgical or radiation treatment for malignancy. E. Pharmacology 1. List major chemotherapeutic agents used for treatment of malignancies of the reproductive organs and breast. 2. Describe the principal adverse effects of the major chemotherapeutic agents. 3. Describe the medications of most value in treatment of complications resulting from chemotherapy and irradiation, such as: a.
    [Show full text]
  • A Discursive Approach to Female Circumcision: Why the United Nations Should Drop the One-Sided Conversation in Favor of the Vagina Dialogues
    NORTH CAROLINA JOURNAL OF INTERNATIONAL LAW Volume 38 Number 2 Article 6 Winter 2013 A Discursive Approach to Female Circumcision: Why the United Nations Should Drop the One-Sided Conversation in Favor of the Vagina Dialogues Kathleen Bradshaw Follow this and additional works at: https://scholarship.law.unc.edu/ncilj Recommended Citation Kathleen Bradshaw, A Discursive Approach to Female Circumcision: Why the United Nations Should Drop the One-Sided Conversation in Favor of the Vagina Dialogues, 38 N.C. J. INT'L L. 601 (2012). Available at: https://scholarship.law.unc.edu/ncilj/vol38/iss2/6 This Note is brought to you for free and open access by Carolina Law Scholarship Repository. It has been accepted for inclusion in North Carolina Journal of International Law by an authorized editor of Carolina Law Scholarship Repository. For more information, please contact [email protected]. A Discursive Approach to Female Circumcision: Why the United Nations Should Drop the One-Sided Conversation in Favor of the Vagina Dialogues Cover Page Footnote International Law; Commercial Law; Law This note is available in North Carolina Journal of International Law: https://scholarship.law.unc.edu/ncilj/vol38/iss2/ 6 A Discursive Approach to Female Circumcision: Why the United Nations Should Drop the One-Sided Conversation in Favor of the Vagina Dialogues KATHLEEN BRADSHAWt I. Introduction ........................................602 II. Background................................ 608 A. Female Circumcision ...................... 608 B. International Legal Response....................610 III. Discussion......................... ........ 613 A. Foreign Domestic Legislation............. ... .......... 616 B. Enforcement.. ...................... ...... 617 C. Cultural Insensitivity: Bad for Development..............620 1. Human Rights, Culture, and Development: The United Nations ................... ............... 621 2.
    [Show full text]
  • Physiology of Female Sexual Function and Dysfunction
    International Journal of Impotence Research (2005) 17, S44–S51 & 2005 Nature Publishing Group All rights reserved 0955-9930/05 $30.00 www.nature.com/ijir Physiology of female sexual function and dysfunction JR Berman1* 1Director Female Urology and Female Sexual Medicine, Rodeo Drive Women’s Health Center, Beverly Hills, California, USA Female sexual dysfunction is age-related, progressive, and highly prevalent, affecting 30–50% of American women. While there are emotional and relational elements to female sexual function and response, female sexual dysfunction can occur secondary to medical problems and have an organic basis. This paper addresses anatomy and physiology of normal female sexual function as well as the pathophysiology of female sexual dysfunction. Although the female sexual response is inherently difficult to evaluate in the clinical setting, a variety of instruments have been developed for assessing subjective measures of sexual arousal and function. Objective measurements used in conjunction with the subjective assessment help diagnose potential physiologic/organic abnormal- ities. Therapeutic options for the treatment of female sexual dysfunction, including hormonal, and pharmacological, are also addressed. International Journal of Impotence Research (2005) 17, S44–S51. doi:10.1038/sj.ijir.3901428 Keywords: female sexual dysfunction; anatomy; physiology; pathophysiology; evaluation; treatment Incidence of female sexual dysfunction updated the definitions and classifications based upon current research and clinical practice.
    [Show full text]
  • Vaginal Screening After Hysterectomy in Australia
    CATEGORY: BEST PRACTICE Vaginal screening after hysterectomy in Australia Objectives: To provide advice on vaginal This statement has been developed and screening after hysterectomy. reviewed by the Women’s Health Committee and approved by the RANZCOG Target audience: Health professionals Board and Council. providing gynaecological care. A list of Women’s Health Committee Values: The evidence was reviewed by the Members can be found in Appendix A. Women’s Health Committee (RANZCOG), and applied to local factors relating to Disclosure statements have been received Australia. from all members of this committee. Background: This statement was first developed by Women’s Health Disclaimer This information is intended to Committee in November 2010 and provide general advice to practitioners. This reviewed in March 2020. information should not be relied on as a substitute for proper assessment with respect Funding: This statement was developed by to the particular circumstances of each RANZCOG and there are no relevant case and the needs of any patient. This financial disclosures. document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The document has been prepared having regard to general circumstances. First endorsed by RANZCOG: November 2010 Current: March 2020 Review due: March 2023 1 1. Introduction In December 2017, the National Cervical Screening Program in Australia changed from 2 yearly cervical cytology testing to 5 yearly primary HPV screening with reflex liquid-based cytology for those women in whom oncogenic HPV is detected in women aged 25–74 years. New Zealand has not yet transitioned to primary HPV screening.
    [Show full text]
  • A New Anatomic and Staging-Oriented Classification Of
    cancers Perspective A New Anatomic and Staging-Oriented Classification of Radical Hysterectomy Mustafa Zelal Muallem Department of Gynecology with Center for Oncological Surgery, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Virchow Campus Clinic, Charité Medical University, 13353 Berlin, Germany; [email protected]; Tel.: +49-30-450-664373; Fax: +49-30-450-564900 Simple Summary: The main deficits of the available classifications of radical hysterectomy are the facts that they are based only on the lateral extension of resection, do not depend on the precise anatomy of parametrium and paracolpium and do not correlate with the tumour stage, size or infiltration in the vagina. This new suggested classification depends on the 3-dimentional concept of parametrium and paracolpium and the comprehensive description of the anatomy of parametrium, paracolpium and the pelvic autonomic nerve system. Each type in this classification tailored to the tumour stage according to FIGO- classification from 2018, taking into account the tumour size, localization and infiltration in the vaginal vault, which may make it the most suitable tool for planning and tailoring the surgery of radical hysterectomy. Abstract: The current understanding of radical hysterectomy more is centered on the uterus and little is being discussed about the resection of the vaginal cuff and the paracolpium as an essential part of this procedure. This is because that the current classifications of radical hysterectomy are based only on the lateral extent of resection. This way is easier to be understood but does not reflect Citation: Muallem, M.Z.
    [Show full text]
  • OBGYN Student Guide 2014.Pdf
    TABLE OF CONTENTS COMMON ABBREVIATIONS • 3 COMMON PRESCRIPTIONS • 4 OBSTETRICS • 5 What is a normal morning like on OB? • 5 What are good questions to ask a post-op/post-partum patient in the morning? • 6 How do I manage a post-partum patient? • 7 How should I organize and write my post-partum note? • 8 How do I present a patient on rounds? • 9 How do I evaluate a patient in triage/L&D? • 9 What are the most common complaints presented at triage/L&D? • 10 How should I organize and write my note for a triage H&P? • 12 What are the most common reasons people are admitted? • 13 How do I deliver a baby? • 13 What is my role as a student in a Cesarean section or tubal ligation procedure? • 15 How do I write up post-op orders? • 15 GYNECOLOGY/GYNECOLOGY ONCOLOGY • 17 What should I do to prepare for a GYN surgery? • 17 How do I manage a Gynecology/Gynecology Oncology patient? • 17 How should I organize and write my post-op GYN note? • 18 How do I write admit orders? • 19 What do routine post-op orders (Day #1) look like? • 19 What are the most common causes of post-operative fever? • 20 CLINIC • 21 What is my role as a student in clinic? • 21 What should I include in my prenatal clinic note? • 21 What should I include in my GYN clinic note? • 22 COMMON PIMP QUESTIONS • 23 2 COMMON ABBREVIATIONS 1°LTCS- primary low transverse cesarean LOF- leakage of fluid section NST- nonstress test AFI- amniotic fluid index NSVD- normal spontaneous vaginal delivery AROM- artificial rupture of membranes NT/NE- non-tender/non-engorged (breast BPP- biophysical
    [Show full text]
  • FGM in Canada
    Compiled by Patricia Huston MD, MPH Scientific Communications International, Inc for the Federal Interdepartmental Working Group on FGM. Copies of this report are available from: Women's Health Bureau Health Canada [email protected] The Canadian Women's Health Network 203-419 Graham Avenue Winnipeg, Manitoba R3C 0M3 fax: (204)989-2355 The opinions expressed in this report are not necessarily those of the Government of Canada or any of the other organizations represented. Dedication This report is dedicated to all the women in the world who have undergone FGM and to all the people who are helping them live with and reverse this procedure. This report is part of the ongoing commitment of Canadians and the Government of Canada to stop this practice in Canada and to improve the health and well-being of affected women and their communities. Executive Summary Female genital mutilation (FGM), or the ritual excision of part or all of the external female genitalia, is an ancient cultural practice that occurs around the world today, especially in Africa. With recent immigration to Canada of peoples from Somalia, Ethiopia and Eritrea, Sudan and Nigeria, women who have undergone this practice are now increasingly living in Canada. It is firmly believed by the people who practise it, that FGM improves feminine hygiene, that it will help eliminate disease and it is thought to be the only way to preserve family honour, a girl's virginity and her marriageability. FGM has a number of important adverse health effects including risks of infection and excessive bleeding (often performed when a girl is pre-pubertal).
    [Show full text]
  • Female Pelvic Relaxation
    FEMALE PELVIC RELAXATION A Primer for Women with Pelvic Organ Prolapse Written by: ANDREW SIEGEL, M.D. An educational service provided by: BERGEN UROLOGICAL ASSOCIATES N.J. CENTER FOR PROSTATE CANCER & UROLOGY Andrew Siegel, M.D. • Martin Goldstein, M.D. Vincent Lanteri, M.D. • Michael Esposito, M.D. • Mutahar Ahmed, M.D. Gregory Lovallo, M.D. • Thomas Christiano, M.D. 255 Spring Valley Avenue Maywood, N.J. 07607 www.bergenurological.com www.roboticurology.com Table of Contents INTRODUCTION .................................................................1 WHY A UROLOGIST? ..........................................................2 PELVIC ANATOMY ..............................................................4 PROLAPSE URETHRA ....................................................................7 BLADDER .....................................................................7 RECTUM ......................................................................8 PERINEUM ..................................................................9 SMALL INTESTINE .....................................................9 VAGINAL VAULT .......................................................10 UTERUS .....................................................................11 EVALUATION OF PROLAPSE ............................................11 SURGICAL REPAIR OF PELVIC PROLAPSE .....................15 STRESS INCONTINENCE .........................................16 CYSTOCELE ..............................................................18 RECTOCELE/PERINEAL LAXITY .............................19
    [Show full text]
  • Oophorectomy Or Salpingectomy— Which Makes More Sense?
    Oophorectomy or salpingectomy— which makes more sense? During hysterectomy for benign indications, many surgeons routinely remove the ovaries to prevent cancer. Here’s what we know about this practice. William H. Parker, MD CASE Patient opts for hysterectomy, asks than age 45 to prevent the subsequent devel- about oophorectomy opment of ovarian cancer (FIGURES 1 and 2). Your 46-year-old patient reports increasingly The 2002 Women’s Health Initiative re- severe dysmenorrhea at her annual visit, and a port suggested that exogenous hormone use pelvic examination reveals an enlarged uterus. was associated with a slight increase in the You order pelvic magnetic resonance imaging, risk of breast cancer.2 After its publication, which shows extensive adenomyosis. the rate of oophorectomy at the time of hys- After you counsel the patient about terectomy declined slightly, likely reflect- IN THIS her options, she elects to undergo lapa- ARTICLE ing women’s desire to preserve their own roscopic supracervical hysterectomy and source of estrogen.3 For women younger Algorithm: Should asks whether she should have her ovaries than age 50, further slight declines in the rate the ovaries removed at the time of surgery. She has no of oophorectomy were seen from 2002 to be removed? family history of ovarian or breast cancer. 2010. However, in the United States, almost page 54 What would you recommend for this 300,000 women still undergo “prophylactic” woman, based on her situation and current bilateral salpingo-oophorectomy every year.4 medical research? The lifetime risk of ovarian cancer Ovarian cancer does among women with a BRCA 1 mutation not come from the prophylactic procedure should be is 36% to 46%, and it is 10% to 27% among ovary considered only if 1) there is a rea- women with a BRCA 2 mutation.
    [Show full text]
  • Japan Society of Gynecologic Oncology Guidelines 2015 for the Treatment of Vulvar Cancer and Vaginal Cancer
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Tsukuba Repository Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer 著者 Saito Toshiaki, Tabata Tsutomu, Ikushima Hitoshi, Yanai Hiroyuki, Tashiro Hironori, Niikura Hitoshi, Minaguchi Takeo, Muramatsu Toshinari, Baba Tsukasa, Yamagami Wataru, Ariyoshi Kazuya, Ushijima Kimio, Mikami Mikio, Nagase Satoru, Kaneuchi Masanori, Yaegashi Nobuo, Udagawa Yasuhiro, Katabuchi Hidetaka journal or International Journal of Clinical Oncology publication title volume 23 number 2 page range 201-234 year 2018-04 権利 (C) The Author(s) 2017. This article is an open access publication This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons. org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. URL http://hdl.handle.net/2241/00151712 doi: 10.1007/s10147-017-1193-z Creative Commons : 表示 http://creativecommons.org/licenses/by/3.0/deed.ja Int J Clin Oncol (2018) 23:201–234 https://doi.org/10.1007/s10147-017-1193-z SPECIAL ARTICLE Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer Toshiaki Saito1 · Tsutomu Tabata2 · Hitoshi Ikushima3 · Hiroyuki Yanai4 · Hironori Tashiro5 · Hitoshi Niikura6 · Takeo Minaguchi7 · Toshinari Muramatsu8 · Tsukasa Baba9 · Wataru Yamagami10 · Kazuya Ariyoshi1 · Kimio Ushijima11 · Mikio Mikami8 · Satoru Nagase12 · Masanori Kaneuchi13 · Nobuo Yaegashi6 · Yasuhiro Udagawa14 · Hidetaka Katabuchi5 Received: 29 August 2017 / Accepted: 5 September 2017 / Published online: 20 November 2017 © The Author(s) 2017.
    [Show full text]
  • Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010
    Policy Name: Once in a Lifetime Procedures Once in a Lifetime Procedures Code List 2019 Effective: 11/14/2010 Family Rhinectomy Code Description 30160 Rhinectomy; total Family Laryngectomy Code Description 31360 Laryngectomy; total, without radical neck dissection 31365 Laryngectomy; total, with radical neck dissection Family Pneumonectomy Code Description 32440 Removal of lung, pneumonectomy; Removal of lung, pneumonectomy; with resection of segment of trachea followed by 32442 broncho-tracheal anastomosis (sleeve pneumonectomy) 32445 Removal of lung, pneumonectomy; extrapleural Family Splenectomy Code Description 38100 Splenectomy; total (separate procedure) Splenectomy; total, en bloc for extensive disease, in conjunction with other procedure (List 38102 in addition to code for primary procedure) Family Glossectomy Code Description Glossectomy; complete or total, with or without tracheostomy, without radical neck 41140 dissection Glossectomy; complete or total, with or without tracheostomy, with unilateral radical neck 41145 dissection Family Uvulectomy Code Description 42140 Uvulectomy, excision of uvula Family Gastrectomy Code Description 43620 Gastrectomy, total; with esophagoenterostomy 43621 Gastrectomy, total; with Roux-en-Y reconstruction 43622 Gastrectomy, total; with formation of intestinal pouch, any type Family Colectomy Code Description 44150 Colectomy, total, abdominal, without proctectomy; with ileostomy or ileoproctostomy 44151 Colectomy, total, abdominal, without proctectomy; with continent ileostomy 44155 Colectomy,
    [Show full text]